Plymouth Meeting based Geneos Therapeutics is developing DNA-based personalized therapeutic cancer vaccines

blonca9
Sep 20, 2024
1 min read

Founder and CEO Niranjan Sardesai describes why is believes a personalized approach is important and how Geneos is working on the technology, which is currently in phase 2 in advanced liver cancer.

Recent Posts

See All

On its 10-year anniversary, Arcus Biosciences is taking its 4th molecule into pivotal studies. Co-Founder & CEO Terry Rosen talks HIF-2⍺, TIGIT, and CD73

Siren Biotechnology is using an online platform to raise up to $5 million from the public in a "community round" - it might be a new avenue of funding for biotech companies

Theravance Biopharma has a key pivotal trial readout scheduled for late '25 / early '26 in symptomatic neurogenic orthostatic hypotension (nOH) in patients with multiple system atrophy (MSA)

Plymouth Meeting based Geneos Therapeutics is developing DNA-based personalized therapeutic cancer vaccines

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight